JP2017502662A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017502662A5 JP2017502662A5 JP2016540591A JP2016540591A JP2017502662A5 JP 2017502662 A5 JP2017502662 A5 JP 2017502662A5 JP 2016540591 A JP2016540591 A JP 2016540591A JP 2016540591 A JP2016540591 A JP 2016540591A JP 2017502662 A5 JP2017502662 A5 JP 2017502662A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- virus
- acid molecule
- prrs virus
- prrs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000700605 Viruses Species 0.000 claims 11
- 150000007523 nucleic acids Chemical class 0.000 claims 10
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 claims 9
- 108020004707 nucleic acids Proteins 0.000 claims 8
- 102000039446 nucleic acids Human genes 0.000 claims 8
- 108020004414 DNA Proteins 0.000 claims 6
- 241001465754 Metazoa Species 0.000 claims 3
- 241000282898 Sus scrofa Species 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 102000053602 DNA Human genes 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 230000000241 respiratory effect Effects 0.000 claims 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 1
- 230000002238 attenuated effect Effects 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 230000001850 reproductive effect Effects 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13199177.0 | 2013-12-20 | ||
| EP13199177 | 2013-12-20 | ||
| EP14175691.6 | 2014-07-03 | ||
| EP14175691 | 2014-07-03 | ||
| PCT/EP2014/078929 WO2015092058A1 (en) | 2013-12-20 | 2014-12-19 | Prrs virus variant, european prrs virus cdna clone, and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019230014A Division JP2020054380A (ja) | 2013-12-20 | 2019-12-20 | ＰＲＲＳウイルス変異株、ヨーロッパ型ＰＲＲＳウイルスｃＤＮＡクローンおよびそれらの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017502662A JP2017502662A (ja) | 2017-01-26 |
| JP2017502662A5 true JP2017502662A5 (enExample) | 2018-02-08 |
| JP6886291B2 JP6886291B2 (ja) | 2021-06-16 |
Family
ID=52347295
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016540591A Active JP6886291B2 (ja) | 2013-12-20 | 2014-12-19 | ＰＲＲＳウイルス変異株、ヨーロッパ型ＰＲＲＳウイルスｃＤＮＡクローンおよびそれらの使用 |
| JP2019230014A Withdrawn JP2020054380A (ja) | 2013-12-20 | 2019-12-20 | ＰＲＲＳウイルス変異株、ヨーロッパ型ＰＲＲＳウイルスｃＤＮＡクローンおよびそれらの使用 |
| JP2021049537A Active JP7158523B2 (ja) | 2013-12-20 | 2021-03-24 | ＰＲＲＳウイルス変異株、ヨーロッパ型ＰＲＲＳウイルスｃＤＮＡクローンおよびそれらの使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019230014A Withdrawn JP2020054380A (ja) | 2013-12-20 | 2019-12-20 | ＰＲＲＳウイルス変異株、ヨーロッパ型ＰＲＲＳウイルスｃＤＮＡクローンおよびそれらの使用 |
| JP2021049537A Active JP7158523B2 (ja) | 2013-12-20 | 2021-03-24 | ＰＲＲＳウイルス変異株、ヨーロッパ型ＰＲＲＳウイルスｃＤＮＡクローンおよびそれらの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10010601B2 (enExample) |
| EP (2) | EP3083947B1 (enExample) |
| JP (3) | JP6886291B2 (enExample) |
| KR (2) | KR102270344B1 (enExample) |
| CN (1) | CN105829528B (enExample) |
| AU (2) | AU2014369774B2 (enExample) |
| CA (1) | CA2930042C (enExample) |
| DK (2) | DK3591042T5 (enExample) |
| EA (1) | EA039060B1 (enExample) |
| ES (2) | ES2940691T3 (enExample) |
| HU (1) | HUE061768T2 (enExample) |
| MX (2) | MX2020010248A (enExample) |
| WO (1) | WO2015092058A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012217170B2 (en) | 2011-02-17 | 2016-07-28 | Boehringer Ingelheim Vetmedica Gmbh | Commercial scale process for production of PRRSV |
| WO2012110489A2 (en) | 2011-02-17 | 2012-08-23 | Boehringer Ingelheim Vetmedica Gmbh | Novel european prrsv strain |
| AU2014369774B2 (en) | 2013-12-20 | 2020-11-26 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus variant, European PRRS virus cDNA clone, and uses thereof |
| MX393666B (es) | 2016-08-05 | 2025-03-24 | Hipra Scient S L U | CLON DE ADNc DEL VIRUS DEL SÍNDROME REPRODUCTIVO Y RESPIRATORIO PORCINO Y USOS DEL MISMO. |
| WO2020138761A1 (ko) * | 2018-12-27 | 2020-07-02 | 주식회사 바이오포아 | 돼지 생식기 및 호흡기 증후군 바이러스의 키메라 바이러스 및 이를 이용한 백신 |
| KR102335864B1 (ko) * | 2018-12-27 | 2021-12-06 | 주식회사 바이오포아 | 돼지 생식기 및 호흡기 증후군 바이러스의 키메라 바이러스 및 이를 이용한 백신 |
| US12214032B2 (en) | 2019-08-29 | 2025-02-04 | Elanco Uk Ah Limited | Porcine Reproductive and Respiratory Syndrome vaccine virus |
| CN110894243B (zh) * | 2019-12-16 | 2021-07-13 | 中国农业大学 | 一种猪蓝耳病毒嵌合抗原以及检测猪蓝耳病毒抗体的胶体金免疫层析试纸条 |
| KR102764120B1 (ko) | 2019-12-31 | 2025-02-06 | 엘릭서젠 쎄라퓨틱스, 인크. | 핵산 및 단백질의 세포 및 조직으로의 온도-기반 일시적 전달 |
| JP2021153692A (ja) * | 2020-03-25 | 2021-10-07 | 株式会社三共 | 遊技機 |
| KR102319508B1 (ko) * | 2020-07-27 | 2021-10-28 | 연세대학교 산학협력단 | 인체 감염형 낙타 유래 메르스코로나바이러스 검출용 바이오마커 및 이의 용도 |
| CN113969267B (zh) * | 2021-11-15 | 2024-02-27 | 中国农业大学 | 一种猪繁殖与呼吸综合征突变病毒及其构建方法与应用 |
| WO2024077281A2 (en) * | 2022-10-06 | 2024-04-11 | Cornell University | Genotyping and sequencing assays for prrsv |
| KR20240146158A (ko) * | 2023-03-27 | 2024-10-08 | 주식회사 케어사이드 | 돼지생식기호흡기증후군 키메릭 바이러스 및 이를 이용한 백신 조성물 |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3137631A (en) | 1959-12-01 | 1964-06-16 | Faberge Inc | Encapsulation in natural products |
| US3959457A (en) | 1970-06-05 | 1976-05-25 | Temple University | Microparticulate material and method of making such material |
| US4015100A (en) | 1974-01-07 | 1977-03-29 | Avco Everett Research Laboratory, Inc. | Surface modification |
| EP0000062A1 (en) | 1977-06-07 | 1978-12-20 | Joseph George Spitzer | Vapor tap valve for aerosol containers used with inflammable propellants, and container provided therewith |
| US4205060A (en) | 1978-12-20 | 1980-05-27 | Pennwalt Corporation | Microcapsules containing medicament-polymer salt having a water-insoluble polymer sheath, their production and their use |
| ZA864879B (en) | 1985-07-08 | 1987-03-25 | Wallone Region | Vaccines and diagnostics derived from boving diarrhoea virus |
| NZ222465A (en) | 1986-11-07 | 1992-11-25 | Pasteur Institut | Nanb (non a, non b hepatitis viral) antigen |
| DE69201441T3 (de) | 1991-06-06 | 2008-12-04 | Boehringer Ingelheim Vetmedica Gmbh | Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits. |
| US6042830A (en) | 1992-08-05 | 2000-03-28 | Boehringer Ingelheim Vetmedica, Inc. | Viral agent associated with mystery swine disease |
| AU2684792A (en) | 1991-10-14 | 1993-05-21 | Akzo Nobel N.V. | Porcine reproductive respiratory syndrome vaccine and diagnostic |
| FR2686097B1 (fr) | 1992-01-14 | 1994-12-30 | Rhone Merieux | Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie. |
| US5695766A (en) | 1992-10-30 | 1997-12-09 | Iowa State University Research Foundation | Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome |
| ES2074950B1 (es) | 1993-09-17 | 1996-03-16 | Iberica Cyanamid | Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda. |
| DE69522984T2 (de) | 1994-04-11 | 2002-04-25 | Akzo Nobel Nv | Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Schweins |
| DK53595A (da) | 1994-05-13 | 1995-11-14 | Iberica Cyanamid | Rekombinante PRRSV-proteiner, diagnostiske kits og vaccine indeholdende sådanne rekombinante PRRSV-proteiner |
| DE69632658T2 (de) | 1995-03-14 | 2005-06-09 | Akzo Nobel N.V. | Expression in der selben Zelle von Polypeptide vom schweinen reproduktiven und respiratorischen Syndrom |
| ES2102971B1 (es) | 1996-01-25 | 1998-03-01 | Hipra Lab Sa | Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion. |
| US5866401A (en) | 1996-03-01 | 1999-02-02 | Schering Corporation | Porcine reproductive and respiratory syndrome vaccine |
| ES2157522T3 (es) | 1996-10-09 | 2001-08-16 | Akzo Nobel Nv | Cepas de vacunas europeas del virus del sindrome respiratorio reproductor porcino (prrsv). |
| EP0839912A1 (en) | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| US20040224327A1 (en) | 1996-10-30 | 2004-11-11 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| EP1882696A3 (en) | 1997-05-06 | 2008-03-05 | Boehringer Ingelheim Vetmedica Gmbh | PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays |
| NZ513289A (en) | 1998-12-22 | 2003-04-29 | Pfizer Prod Inc | Infectious cDNA clone of north american procine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| JP3961222B2 (ja) | 1999-03-08 | 2007-08-22 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | Ｐｒｒｓｖワクチン |
| EP1183332B1 (en) | 1999-04-22 | 2010-07-14 | United States Department Of Agriculture | Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
| WO2002095040A1 (en) | 2001-05-21 | 2002-11-28 | Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. | Delections in arterivirus replicons |
| CA2400583A1 (en) | 2000-02-08 | 2001-08-16 | Regents Of The University Of Minnesota | Porcine reproductive and respiratory syndrome virus and methods of use |
| EP1156111A1 (en) | 2000-05-19 | 2001-11-21 | Stichting Dienst Landbouwkundig Onderzoek | Chimeric arterivirus-like particles |
| EP1350840B1 (en) | 2002-04-05 | 2012-05-09 | Boehringer Ingelheim Vetmedica GmbH | Adaptation sites of PRRSV |
| US7722878B2 (en) | 2004-06-17 | 2010-05-25 | Boehringer Ingelheim Vetmedica, Inc. | PRRSV subunit vaccines |
| US7632636B2 (en) | 2004-09-21 | 2009-12-15 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome isolates and methods of use |
| CA2587321A1 (en) | 2005-01-13 | 2006-07-20 | Boehringer Ingelheim Vetmedica Gmbh | Improved prrs vaccines |
| WO2008121958A1 (en) | 2007-04-02 | 2008-10-09 | Boehringer Ingelheim Vetmedica, Inc. | Use of prrsv vaccines to reduce pcv2 viremia |
| ES2389748T3 (es) * | 2007-06-25 | 2012-10-31 | South Dakota State University | Virus del síndrome reproductivo y respiratorio porcino de tipo 1 norteamericano recombinante y métodos de uso |
| JP5619004B2 (ja) | 2008-08-25 | 2014-11-05 | ベーリンガーインゲルハイム フェトメディカ インコーポレイテッド | 高病原性ブタ繁殖・呼吸障害症候群（ｈｐｐｒｒｓ）のワクチン |
| WO2010084648A1 (ja) | 2009-01-20 | 2010-07-29 | シャープ株式会社 | 照明装置、表示装置、及びテレビ受信装置 |
| WO2011128415A1 (en) | 2010-04-16 | 2011-10-20 | Universiteit Gent | Cross-protecting vaccine for porcine reproductive and respiratory syndrome virus |
| WO2012110489A2 (en) | 2011-02-17 | 2012-08-23 | Boehringer Ingelheim Vetmedica Gmbh | Novel european prrsv strain |
| AU2012217170B2 (en) | 2011-02-17 | 2016-07-28 | Boehringer Ingelheim Vetmedica Gmbh | Commercial scale process for production of PRRSV |
| WO2013017568A1 (en) | 2011-07-29 | 2013-02-07 | Boehringer Ingelheim Vetmedica Gmbh | INFECTIOUS cDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF |
| EA032389B1 (ru) * | 2012-02-14 | 2019-05-31 | Мериал, Инк. | Рекомбинантные поксвирусные векторы, кодирующие и экспрессирующие гликопротеин g вируса бешенства и полипептид oxl, и вакцины, созданные на их основе, используемые в способе вакцинации животных против бешенства |
| MX2014013964A (es) * | 2012-05-17 | 2015-03-04 | Zoetis Llc | Vacunacion eficaz contral el virus del sindrome reproductivo y respiratorio porcino (prrs) antes del destete. |
| US9579373B2 (en) | 2013-03-15 | 2017-02-28 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use |
| EP3084460B1 (en) * | 2013-12-19 | 2021-10-06 | Koninklijke Philips N.V. | Phase-sensitive inversion recovery mri with water/fat separation |
| AU2014369774B2 (en) | 2013-12-20 | 2020-11-26 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus variant, European PRRS virus cDNA clone, and uses thereof |
-
2014
- 2014-12-19 AU AU2014369774A patent/AU2014369774B2/en active Active
- 2014-12-19 ES ES19165389T patent/ES2940691T3/es active Active
- 2014-12-19 KR KR1020167019672A patent/KR102270344B1/ko active Active
- 2014-12-19 WO PCT/EP2014/078929 patent/WO2015092058A1/en not_active Ceased
- 2014-12-19 EP EP14827219.8A patent/EP3083947B1/en active Active
- 2014-12-19 DK DK19165389.8T patent/DK3591042T5/da active
- 2014-12-19 KR KR1020217019360A patent/KR102446025B1/ko active Active
- 2014-12-19 US US15/105,760 patent/US10010601B2/en active Active
- 2014-12-19 EP EP19165389.8A patent/EP3591042B1/en active Active
- 2014-12-19 JP JP2016540591A patent/JP6886291B2/ja active Active
- 2014-12-19 HU HUE19165389A patent/HUE061768T2/hu unknown
- 2014-12-19 MX MX2020010248A patent/MX2020010248A/es unknown
- 2014-12-19 EA EA201600476A patent/EA039060B1/ru unknown
- 2014-12-19 CN CN201480068965.2A patent/CN105829528B/zh active Active
- 2014-12-19 MX MX2016007737A patent/MX375528B/es active IP Right Grant
- 2014-12-19 ES ES14827219T patent/ES2729838T3/es active Active
- 2014-12-19 DK DK14827219.8T patent/DK3083947T3/da active
- 2014-12-19 CA CA2930042A patent/CA2930042C/en active Active
-
2018
- 2018-06-01 US US15/995,560 patent/US10639364B2/en active Active
-
2019
- 2019-12-20 JP JP2019230014A patent/JP2020054380A/ja not_active Withdrawn
-
2021
- 2021-02-25 AU AU2021201224A patent/AU2021201224B2/en active Active
- 2021-03-24 JP JP2021049537A patent/JP7158523B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gowthaman et al. | Infectious laryngotracheitis: Etiology, epidemiology, pathobiology, and advances in diagnosis and control–a comprehensive review | |
| Vander Veen et al. | Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine | |
| Wang et al. | Orf virus: A promising new therapeutic agent | |
| Li et al. | Adjuvant effects of interleukin-18 in DNA vaccination against infectious bursal disease virus in chickens | |
| Wang et al. | Enhancing neutralizing antibody production by an interferon-inducing porcine reproductive and respiratory syndrome virus strain | |
| US11993789B2 (en) | Pichinde virus reverse genetics systems and methods of use | |
| JP2017522907A5 (enExample) | ||
| Nunes et al. | A synthetic biology approach for a vaccine platform against known and newly emerging serotypes of bluetongue virus | |
| Chen et al. | Molecular and antigenic characteristics of Massachusetts genotype infectious bronchitis coronavirus in China | |
| Petro-Turnquist et al. | Swine influenza A virus: challenges and novel vaccine strategies | |
| Sun et al. | Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain | |
| Wang et al. | Colloidal manganese salt improves the efficacy of rabies vaccines in mice, cats, and dogs | |
| US11123421B2 (en) | Cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal delivery | |
| CN104232594B (zh) | 重组类禽型h1n1流感病毒灭活疫苗株(js40/pr8)及其制备方法和应用 | |
| Hu et al. | Impact of inactivated vaccine on transmission and evolution of H9N2 avian influenza virus in chickens | |
| JP7849046B2 (ja) | インフルエンザウイルスバックボーン | |
| CN103275939B (zh) | 适于细胞培养的嵌合ibv h120 s1基因膜外区的重组病毒及其构建方法和应用 | |
| Wu et al. | Pathogenicity and Whole Genome Sequence Analysis of a Pseudorabies Virus Strain FJ‐2012 Isolated from Fujian, Southern China | |
| Yang et al. | Multiple pathways to evaluate the immunoprotective effect of Turkeys Herpesvirus recombinant vaccine expressing HA of H9N2 | |
| US20210401983A1 (en) | Arthrogenic alphavirus vaccine | |
| Kim et al. | Cross-protective immune responses elicited by a Korean variant of infectious bronchitis virus | |
| Yi et al. | Molecular characterization of a virulent genotype VIId strain of Newcastle disease virus from farmed chickens in Shanghai | |
| Allam et al. | Perspective vaccines for emerging viral diseases in farm animals | |
| JP2012517239A5 (enExample) | ||
| ES2842595T3 (es) | Vacuna contra la rinitis equina |